Table 2.
Changes | Transplant (n = 29) | Nontransplant (n = 29) |
Average aPTT, seconds | 72.6 ± 43.1 | 78.1 ± 50.6 |
Average highest aPTT/patient, seconds | 157.4 ± 59.8 | 147.3 ± 74.4 |
Patients with >1 supratherapeutic aPTT, % | 86 | 69 |
Supratherapeutic aPTTs/patient, seconds* | 2.86 (range, 0–7) | 1.79 (range, 0–11) |
Total aPTTs/patient, seconds* | 14.1 (range, 2–52) | 7.6 (range, 1–47) |
Average (range) heparin duration, days | 7 ± 4.5 (range, 2–25) | 4.7 ± 4.5(range, 1–26) |
Note: Student t test was performed for normally distributed categorical data, and Mann-Whitney was performed for non-normally distribute categorical data. To calculate percent of patients with at least one supratherapeutic aPTT, the Fisher exact probability test was performed.
*P < .05.